[Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia].

Li Zhou, Jianxiang Wang, Xiao‐Jun Huang, Jianda Hu, Zhixiang ShenPubMed 2013

Abstract

Dasatinib is an effective and safe therapy option and can be used as first-line therapy for newly diagnosed CML-CP patients.
BibTeX
@inproceedings{zhou2013preliminary,
  author = {Li Zhou and Jianxiang Wang and Xiao‐Jun Huang and Jianda Hu and Zhixiang Shen},
  title = {{[Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia].}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure